These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 15075179)
1. Poly(ADP-ribose) polymerase and renal hypothermic preservation injury. Mangino MJ; Ametani M; Szabó C; Southard JH Am J Physiol Renal Physiol; 2004 May; 286(5):F838-47. PubMed ID: 15075179 [TBL] [Abstract][Full Text] [Related]
2. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation. Kaundal RK; Shah KK; Sharma SS Life Sci; 2006 Nov; 79(24):2293-302. PubMed ID: 16935310 [TBL] [Abstract][Full Text] [Related]
4. Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction. Murthy KG; Xiao CY; Mabley JG; Chen M; Szabó C Shock; 2004 Mar; 21(3):230-4. PubMed ID: 14770035 [TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-Ribose) polymerase inhibition improves endothelial dysfunction induced by hypochlorite. Radovits T; Zotkina J; Lin LN; Bömicke T; Arif R; Gerö D; Horváth EM; Karck M; Szabó C; Szabó G Exp Biol Med (Maywood); 2007 Oct; 232(9):1204-12. PubMed ID: 17895528 [TBL] [Abstract][Full Text] [Related]
6. Improved poststorage cardiac function by poly (ADP-ribose) polymerase inhibition: role of phosphatidylinositol 3-kinase Akt pathway. Gao L; Kwan JC; Macdonald PS; Yang L; Preiss T; Hicks M Transplantation; 2007 Aug; 84(3):380-6. PubMed ID: 17700164 [TBL] [Abstract][Full Text] [Related]
7. Effect of preconditioning with triiodothyronine on renal ischemia/reperfusion injury and poly(ADP-ribose) polymerase expression in rats. Ferreyra C; O'Valle F; Osorio JM; Moreno JM; Rodríguez I; Vargas F; Osuna A Transplant Proc; 2009; 41(6):2073-5. PubMed ID: 19715835 [TBL] [Abstract][Full Text] [Related]
8. Effect of PJ-34 PARP-inhibitor on rat liver microcirculation and antioxidant status. Szijártó A; Batmunkh E; Hahn O; Mihály Z; Kreiss A; Kiss A; Lotz G; Schaff Z; Váli L; Blázovics A; Geró D; Szabó C; Kupcsulik P J Surg Res; 2007 Sep; 142(1):72-80. PubMed ID: 17612561 [TBL] [Abstract][Full Text] [Related]
9. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Yu SW; Wang H; Poitras MF; Coombs C; Bowers WJ; Federoff HJ; Poirier GG; Dawson TM; Dawson VL Science; 2002 Jul; 297(5579):259-63. PubMed ID: 12114629 [TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by reactive oxidant hydrogen peroxide in vitro. Radovits T; Lin LN; Zotkina J; Gero D; Szabó C; Karck M; Szabó G Eur J Pharmacol; 2007 Jun; 564(1-3):158-66. PubMed ID: 17397824 [TBL] [Abstract][Full Text] [Related]
11. Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats. Lenzsér G; Kis B; Snipes JA; Gáspár T; Sándor P; Komjáti K; Szabó C; Busija DW J Cereb Blood Flow Metab; 2007 Jul; 27(7):1318-26. PubMed ID: 17213862 [TBL] [Abstract][Full Text] [Related]
12. Post-treatment at 12 or 18 hours with 3-aminobenzamide ameliorates retinal ischemia-reperfusion damage. Chiang SK; Lam TT Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3210-4. PubMed ID: 10967085 [TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Moroni F; Meli E; Peruginelli F; Chiarugi A; Cozzi A; Picca R; Romagnoli P; Pellicciari R; Pellegrini-Giampietro DE Cell Death Differ; 2001 Sep; 8(9):921-32. PubMed ID: 11526447 [TBL] [Abstract][Full Text] [Related]
14. 5-Aminoisoquinolinone, a novel inhibitor of poly(adenosine disphosphate-ribose) polymerase, reduces microvascular liver injury but not mortality rate after hepatic ischemia-reperfusion. Khandoga A; Biberthaler P; Enders G; Krombach F Crit Care Med; 2004 Feb; 32(2):472-7. PubMed ID: 14758166 [TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of 5-aminoisoquinolinone, a novel, potent, water-soluble, inhibitor of poly (ADP-ribose) polymerase, in a rat model of splanchnic artery occlusion and reperfusion. Di Paola R; Genovese T; Caputi AP; Threadgill M; Thiemermann C; Cuzzocrea S Eur J Pharmacol; 2004 May; 492(2-3):203-10. PubMed ID: 15178366 [TBL] [Abstract][Full Text] [Related]
17. Different basal NAD levels determine opposite effects of poly(ADP-ribosyl)polymerase inhibitors on H2O2-induced apoptosis. Coppola S; Nosseri C; Maresca V; Ghibelli L Exp Cell Res; 1995 Dec; 221(2):462-9. PubMed ID: 7493646 [TBL] [Abstract][Full Text] [Related]
18. The effects of donor brain death on renal function and arachidonic acid metabolism in a large animal model of hypothermic preservation injury. Mangino MJ; Kosieradzki M; Gilligan B; Woo H; Southard JH Transplantation; 2003 May; 75(10):1640-7. PubMed ID: 12777849 [TBL] [Abstract][Full Text] [Related]
19. Correlation of morphological findings with functional reserve in the aging donor: role of the poly (ADP-ribose) polymerase. O'Valle F; Benitez MC; Gómez-Morales M; Bravo J; Osuna A; del Moral RM; Martin-Oliva D; Oliver FJ; del Moral RG Transplant Proc; 2004 Apr; 36(3):733-5. PubMed ID: 15110646 [TBL] [Abstract][Full Text] [Related]
20. The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts. Pálfi A; Tóth A; Kulcsár G; Hantó K; Deres P; Bartha E; Halmosi R; Szabados E; Czopf L; Kálai T; Hideg K; Sümegi B; Tóth K J Pharmacol Exp Ther; 2005 Oct; 315(1):273-82. PubMed ID: 15951400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]